Search Results

PCI in Practice and Update on Mechanical Circulatory Support

By Christopher Cook, BSc, MBBS, MRCP, PhD, and M. Chadi Alraies, MD

Left Main Stenting in 2020

Integrating EXCEL 5-year data into clinical practice.

By Yousif Ahmad, MD, with commentary from Christopher Cook, BSc, MBBS, MRCP, PhD

Overcoming Anatomic Challenges to Transradial Access

An overview for interventionists who are considering transradial access training.

By Christopher Pyne, MD, FACC, and Tift Mann, MD, FACC

TAVR in Complex Anatomies

Experts share their insights on performing TAVR in bicuspid aortic valves, valve-in-valve procedures, and small aortic annuli, focusing on imaging techniques, valve sizing, procedural risks, and emerging data.

With Toby Rogers, MD; Hemal Gada, MD; Gilbert Tang, MD, MSc, MBA; Christopher Bruce, MD; and Jeremy D. Rier, DO, FACC, FSCAI

An Interview With Christopher J. White, MD

Dr. White discusses regulatory issues, fellowship training, and the evolving role of interventional cardiologists.

Transcatheter Tricuspid Valve Therapies

A look at the current state of this final valve frontier.

By Christopher U. Meduri, MD, MPH; Vivek Rajagopal, MD; Mani A. Vannan, MBBS; Kari Feldt, MD; and Azeem Latib, MD

Reaching TAVR's Full Potential by Optimizing Postprocedure Care

Realizing the potential benefits that can be gained when clinical pathways are implemented post-TAVR.

By Christopher U. Meduri, MD, MPH; Vivek Rajagopal, MD; Jim Kauten, MD; Charles Brown IV, BA; David Alexander, PA; Edvin K. Feldt, MD; and Brian J. Potter, MD, MSc

Learn the Technique

By Azeem Latib, MD, and Guest Chief Antonio Mangieri, MD

Aortic Valve Update & Structural Disease

By Ted E. Feldman, MD, MSCAI, FACC, FESC

The Radial Shift

By Ted E. Feldman, MD, FESC, FACC, FSCAI

Mitral & Tricuspid Transcatheter Therapies

By Ted E. Feldman, MD, MSCAI, FACC, FESC, and Azeem Latib, MD

An Interview With Rasha Al-Lamee, MA, MBBS, FRCP, PhD

Dr. Al-Lamee discusses the importance of research in cardiology care, thoughts on the ORBITA and EXCEL trials, and the effect of COVID-19 on the clinical trial landscape.